AI English summary of an SEC filing — figures as filed

Boston Scientific said Jeffrey B. Mirviss informed the company on August 29, 2025 that he has decided to retire from his role as Executive Vice President and President, Peripheral Interventions effective as of December 1, 2025.

8-KDeparture or Appointment of Directors or Certain OfficersFiled Sep 4, 2025Period of report Aug 29, 2025Summary published (UTC) Oct 13, 2026

Key points

AI summary

Boston Scientific said Jeffrey B. Mirviss informed the company on August 29, 2025 that he has decided to retire from his role as Executive Vice President and President, Peripheral Interventions effective as of December 1, 2025.
The company said Mr. Mirviss is expected to remain with the company as a senior advisor from December 1, 2025 through February 27, 2026, or any earlier date, which is defined as the Retirement Date.
Boston Scientific said Mr. Mirviss will receive a base salary at his current annual base salary of $705,000, prorated through the Retirement Date, as a senior advisor.
The company said it expects to enter into a Retirement Agreement with Mr. Mirviss effective as of the Retirement Date, pursuant to which the payments and benefits will be materially consistent with those under the Executive Retirement Plan and other previously filed plans and programs.

Summary

AI-written

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Jeffrey B. Mirviss Notifies of Retirement

Boston Scientific said Jeffrey B. Mirviss informed the company on August 29, 2025 that he has decided to retire from his role as Executive Vice President and President, Peripheral Interventions effective as of December 1, 2025.

Source · Based on the filing body and exhibits

Senior Advisor Role and Period Following Retirement

The company said Mr. Mirviss is expected to remain with the company as a senior advisor from December 1, 2025 through February 27, 2026, or any earlier date, which is defined as the Retirement Date.

Source · Based on the filing body and exhibits

Senior Advisor Base Salary

Boston Scientific said Mr. Mirviss will receive a base salary at his current annual base salary of $705,000, prorated through the Retirement Date, as a senior advisor.

Source · Based on the filing body and exhibits

Retirement Agreement Expected to Be Entered Into

The company said it expects to enter into a Retirement Agreement with Mr. Mirviss effective as of the Retirement Date, pursuant to which the payments and benefits will be materially consistent with those under the Executive Retirement Plan and other previously filed plans and programs.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗

Unauthorized scraping, data storage and database creation prohibited

Without prior written consent, you must not crawl or scrape data compiled and organized by Chickstock or its analysis and summaries, or collect them repeatedly or in bulk for storage, ingestion or database creation. Repurposing, redistribution, sale and use to build other services are also prohibited.

Unauthorized use may result in access restrictions, demands to stop infringement and delete copies, and claims for damages. Violations of applicable law may also give rise to criminal liability.

Uses permitted by law, the Terms of Service or a separate agreement remain subject to their respective scope. Rights in individual source materials, including original filings, remain with their respective rights holders.